Model-Based Economic Evaluation in Alzheimer's Disease: A Review of the Methods Available to Model Alzheimer's Disease Progression

Abstract Objective To consider the methods available to model Alzheimer's disease (AD) progression over time to inform on the structure and development of model-based evaluations, and the future direction of modelling methods in AD. Methods A systematic search of the health care literature was...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Value in health 2011-07, Vol.14 (5), p.621-630
Hauptverfasser: Green, Colin, PhD, Shearer, James, PhD, Ritchie, Craig W., MBChB, MRCPsych, MSc, DLSHTM, Zajicek, John P., MRCP, FRCP, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 630
container_issue 5
container_start_page 621
container_title Value in health
container_volume 14
creator Green, Colin, PhD
Shearer, James, PhD
Ritchie, Craig W., MBChB, MRCPsych, MSc, DLSHTM
Zajicek, John P., MRCP, FRCP, PhD
description Abstract Objective To consider the methods available to model Alzheimer's disease (AD) progression over time to inform on the structure and development of model-based evaluations, and the future direction of modelling methods in AD. Methods A systematic search of the health care literature was undertaken to identify methods to model disease progression in AD. Modelling methods are presented in a descriptive review. Results The literature search identified 42 studies presenting methods or applications of methods to model AD progression over time. The review identified 10 general modelling frameworks available to empirically model the progression of AD as part of a model-based evaluation. Seven of these general models are statistical models predicting progression of AD using a measure of cognitive function. The main concerns with models are on model structure, around the limited characterization of disease progression, and on the use of a limited number of health states to capture events related to disease progression over time. None of the available models have been able to present a comprehensive model of the natural history of AD. Conclusions Although helpful, there are serious limitations in the methods available to model progression of AD over time. Advances are needed to better model the progression of AD and the effects of the disease on peoples' lives. Recent evidence supports the need for a multivariable approach to the modelling of AD progression, and indicates that a latent variable analytic approach to characterising AD progression is a promising avenue for advances in the statistical development of modelling methods.
doi_str_mv 10.1016/j.jval.2010.12.008
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_883850576</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1098301511001148</els_id><sourcerecordid>883850576</sourcerecordid><originalsourceid>FETCH-LOGICAL-c454t-f79f4ac0e388b5de9f006217c8008fd96ede9a20fb805767e4a5bd04cdfa02aa3</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhSMEoqXwAiyQd11luLaTiYMQ0lCmgNQKxM_acuxrxsGJi51MVZY8OQ5TWCDEytbVOcc-3y2KxxRWFOj6ab_q98qvGCwDtgIQd4pjWrOqrBrO7-Y7tKLkQOuj4kFKPQCsOavvF0eMCt7yVhwXPy6DQV--VAkN2eowhsFpss25s5pcGIkbycZ_36EbMJ4m8solzNpnZEM-4N7hNQmWTDsklzjtgklks1fOq84jmQL5Ff4vP3kfw5eIKeUnHhb3rPIJH92eJ8Xn8-2nszflxbvXb882F6Wu6moqbdPaSmlALkRXG2xtrsNoo0Uubk27xjxTDGwnoG7WDVaq7gxU2lgFTCl-Upwecq9i-DZjmuTgkkbv1YhhTlIILurFmpXsoNQxpBTRyqvoBhVvJAW5oJe9XNDLBb2kTOYfZNOT2_i5G9D8sfxmnQXPDwLMJTO6KJN2OGo0LqKepAnu__kv_rJr70anlf-KN5j6MMcx45NUpmyQH5flL7unFIDSSvCfcUqq7w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>883850576</pqid></control><display><type>article</type><title>Model-Based Economic Evaluation in Alzheimer's Disease: A Review of the Methods Available to Model Alzheimer's Disease Progression</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB Electronic Journals Library</source><creator>Green, Colin, PhD ; Shearer, James, PhD ; Ritchie, Craig W., MBChB, MRCPsych, MSc, DLSHTM ; Zajicek, John P., MRCP, FRCP, PhD</creator><creatorcontrib>Green, Colin, PhD ; Shearer, James, PhD ; Ritchie, Craig W., MBChB, MRCPsych, MSc, DLSHTM ; Zajicek, John P., MRCP, FRCP, PhD</creatorcontrib><description>Abstract Objective To consider the methods available to model Alzheimer's disease (AD) progression over time to inform on the structure and development of model-based evaluations, and the future direction of modelling methods in AD. Methods A systematic search of the health care literature was undertaken to identify methods to model disease progression in AD. Modelling methods are presented in a descriptive review. Results The literature search identified 42 studies presenting methods or applications of methods to model AD progression over time. The review identified 10 general modelling frameworks available to empirically model the progression of AD as part of a model-based evaluation. Seven of these general models are statistical models predicting progression of AD using a measure of cognitive function. The main concerns with models are on model structure, around the limited characterization of disease progression, and on the use of a limited number of health states to capture events related to disease progression over time. None of the available models have been able to present a comprehensive model of the natural history of AD. Conclusions Although helpful, there are serious limitations in the methods available to model progression of AD over time. Advances are needed to better model the progression of AD and the effects of the disease on peoples' lives. Recent evidence supports the need for a multivariable approach to the modelling of AD progression, and indicates that a latent variable analytic approach to characterising AD progression is a promising avenue for advances in the statistical development of modelling methods.</description><identifier>ISSN: 1098-3015</identifier><identifier>EISSN: 1524-4733</identifier><identifier>DOI: 10.1016/j.jval.2010.12.008</identifier><identifier>PMID: 21839398</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alzheimer Disease - diagnosis ; Alzheimer Disease - economics ; Alzheimer Disease - psychology ; Alzheimer Disease - therapy ; Alzheimer's disease ; Cognition ; Cost of Illness ; Cost-Benefit Analysis ; cost-effectiveness analysis ; Decision Support Techniques ; Disease Progression ; Health Care Costs ; Health Services Research - methods ; Health Status Indicators ; health technology assessment ; Humans ; Internal Medicine ; modelling methods ; Models, Economic ; Models, Statistical ; Outcome and Process Assessment, Health Care - economics ; Time Factors ; Treatment Outcome</subject><ispartof>Value in health, 2011-07, Vol.14 (5), p.621-630</ispartof><rights>International Society for Pharmacoeconomics and Outcomes Research (ISPOR)</rights><rights>2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR)</rights><rights>Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c454t-f79f4ac0e388b5de9f006217c8008fd96ede9a20fb805767e4a5bd04cdfa02aa3</citedby><cites>FETCH-LOGICAL-c454t-f79f4ac0e388b5de9f006217c8008fd96ede9a20fb805767e4a5bd04cdfa02aa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1098301511001148$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21839398$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Green, Colin, PhD</creatorcontrib><creatorcontrib>Shearer, James, PhD</creatorcontrib><creatorcontrib>Ritchie, Craig W., MBChB, MRCPsych, MSc, DLSHTM</creatorcontrib><creatorcontrib>Zajicek, John P., MRCP, FRCP, PhD</creatorcontrib><title>Model-Based Economic Evaluation in Alzheimer's Disease: A Review of the Methods Available to Model Alzheimer's Disease Progression</title><title>Value in health</title><addtitle>Value Health</addtitle><description>Abstract Objective To consider the methods available to model Alzheimer's disease (AD) progression over time to inform on the structure and development of model-based evaluations, and the future direction of modelling methods in AD. Methods A systematic search of the health care literature was undertaken to identify methods to model disease progression in AD. Modelling methods are presented in a descriptive review. Results The literature search identified 42 studies presenting methods or applications of methods to model AD progression over time. The review identified 10 general modelling frameworks available to empirically model the progression of AD as part of a model-based evaluation. Seven of these general models are statistical models predicting progression of AD using a measure of cognitive function. The main concerns with models are on model structure, around the limited characterization of disease progression, and on the use of a limited number of health states to capture events related to disease progression over time. None of the available models have been able to present a comprehensive model of the natural history of AD. Conclusions Although helpful, there are serious limitations in the methods available to model progression of AD over time. Advances are needed to better model the progression of AD and the effects of the disease on peoples' lives. Recent evidence supports the need for a multivariable approach to the modelling of AD progression, and indicates that a latent variable analytic approach to characterising AD progression is a promising avenue for advances in the statistical development of modelling methods.</description><subject>Alzheimer Disease - diagnosis</subject><subject>Alzheimer Disease - economics</subject><subject>Alzheimer Disease - psychology</subject><subject>Alzheimer Disease - therapy</subject><subject>Alzheimer's disease</subject><subject>Cognition</subject><subject>Cost of Illness</subject><subject>Cost-Benefit Analysis</subject><subject>cost-effectiveness analysis</subject><subject>Decision Support Techniques</subject><subject>Disease Progression</subject><subject>Health Care Costs</subject><subject>Health Services Research - methods</subject><subject>Health Status Indicators</subject><subject>health technology assessment</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>modelling methods</subject><subject>Models, Economic</subject><subject>Models, Statistical</subject><subject>Outcome and Process Assessment, Health Care - economics</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>1098-3015</issn><issn>1524-4733</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAUhSMEoqXwAiyQd11luLaTiYMQ0lCmgNQKxM_acuxrxsGJi51MVZY8OQ5TWCDEytbVOcc-3y2KxxRWFOj6ab_q98qvGCwDtgIQd4pjWrOqrBrO7-Y7tKLkQOuj4kFKPQCsOavvF0eMCt7yVhwXPy6DQV--VAkN2eowhsFpss25s5pcGIkbycZ_36EbMJ4m8solzNpnZEM-4N7hNQmWTDsklzjtgklks1fOq84jmQL5Ff4vP3kfw5eIKeUnHhb3rPIJH92eJ8Xn8-2nszflxbvXb882F6Wu6moqbdPaSmlALkRXG2xtrsNoo0Uubk27xjxTDGwnoG7WDVaq7gxU2lgFTCl-Upwecq9i-DZjmuTgkkbv1YhhTlIILurFmpXsoNQxpBTRyqvoBhVvJAW5oJe9XNDLBb2kTOYfZNOT2_i5G9D8sfxmnQXPDwLMJTO6KJN2OGo0LqKepAnu__kv_rJr70anlf-KN5j6MMcx45NUpmyQH5flL7unFIDSSvCfcUqq7w</recordid><startdate>20110701</startdate><enddate>20110701</enddate><creator>Green, Colin, PhD</creator><creator>Shearer, James, PhD</creator><creator>Ritchie, Craig W., MBChB, MRCPsych, MSc, DLSHTM</creator><creator>Zajicek, John P., MRCP, FRCP, PhD</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110701</creationdate><title>Model-Based Economic Evaluation in Alzheimer's Disease: A Review of the Methods Available to Model Alzheimer's Disease Progression</title><author>Green, Colin, PhD ; Shearer, James, PhD ; Ritchie, Craig W., MBChB, MRCPsych, MSc, DLSHTM ; Zajicek, John P., MRCP, FRCP, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c454t-f79f4ac0e388b5de9f006217c8008fd96ede9a20fb805767e4a5bd04cdfa02aa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Alzheimer Disease - diagnosis</topic><topic>Alzheimer Disease - economics</topic><topic>Alzheimer Disease - psychology</topic><topic>Alzheimer Disease - therapy</topic><topic>Alzheimer's disease</topic><topic>Cognition</topic><topic>Cost of Illness</topic><topic>Cost-Benefit Analysis</topic><topic>cost-effectiveness analysis</topic><topic>Decision Support Techniques</topic><topic>Disease Progression</topic><topic>Health Care Costs</topic><topic>Health Services Research - methods</topic><topic>Health Status Indicators</topic><topic>health technology assessment</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>modelling methods</topic><topic>Models, Economic</topic><topic>Models, Statistical</topic><topic>Outcome and Process Assessment, Health Care - economics</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Green, Colin, PhD</creatorcontrib><creatorcontrib>Shearer, James, PhD</creatorcontrib><creatorcontrib>Ritchie, Craig W., MBChB, MRCPsych, MSc, DLSHTM</creatorcontrib><creatorcontrib>Zajicek, John P., MRCP, FRCP, PhD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Value in health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Green, Colin, PhD</au><au>Shearer, James, PhD</au><au>Ritchie, Craig W., MBChB, MRCPsych, MSc, DLSHTM</au><au>Zajicek, John P., MRCP, FRCP, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Model-Based Economic Evaluation in Alzheimer's Disease: A Review of the Methods Available to Model Alzheimer's Disease Progression</atitle><jtitle>Value in health</jtitle><addtitle>Value Health</addtitle><date>2011-07-01</date><risdate>2011</risdate><volume>14</volume><issue>5</issue><spage>621</spage><epage>630</epage><pages>621-630</pages><issn>1098-3015</issn><eissn>1524-4733</eissn><abstract>Abstract Objective To consider the methods available to model Alzheimer's disease (AD) progression over time to inform on the structure and development of model-based evaluations, and the future direction of modelling methods in AD. Methods A systematic search of the health care literature was undertaken to identify methods to model disease progression in AD. Modelling methods are presented in a descriptive review. Results The literature search identified 42 studies presenting methods or applications of methods to model AD progression over time. The review identified 10 general modelling frameworks available to empirically model the progression of AD as part of a model-based evaluation. Seven of these general models are statistical models predicting progression of AD using a measure of cognitive function. The main concerns with models are on model structure, around the limited characterization of disease progression, and on the use of a limited number of health states to capture events related to disease progression over time. None of the available models have been able to present a comprehensive model of the natural history of AD. Conclusions Although helpful, there are serious limitations in the methods available to model progression of AD over time. Advances are needed to better model the progression of AD and the effects of the disease on peoples' lives. Recent evidence supports the need for a multivariable approach to the modelling of AD progression, and indicates that a latent variable analytic approach to characterising AD progression is a promising avenue for advances in the statistical development of modelling methods.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>21839398</pmid><doi>10.1016/j.jval.2010.12.008</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1098-3015
ispartof Value in health, 2011-07, Vol.14 (5), p.621-630
issn 1098-3015
1524-4733
language eng
recordid cdi_proquest_miscellaneous_883850576
source MEDLINE; Elsevier ScienceDirect Journals; EZB Electronic Journals Library
subjects Alzheimer Disease - diagnosis
Alzheimer Disease - economics
Alzheimer Disease - psychology
Alzheimer Disease - therapy
Alzheimer's disease
Cognition
Cost of Illness
Cost-Benefit Analysis
cost-effectiveness analysis
Decision Support Techniques
Disease Progression
Health Care Costs
Health Services Research - methods
Health Status Indicators
health technology assessment
Humans
Internal Medicine
modelling methods
Models, Economic
Models, Statistical
Outcome and Process Assessment, Health Care - economics
Time Factors
Treatment Outcome
title Model-Based Economic Evaluation in Alzheimer's Disease: A Review of the Methods Available to Model Alzheimer's Disease Progression
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T08%3A29%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Model-Based%20Economic%20Evaluation%20in%20Alzheimer's%20Disease:%20A%20Review%20of%20the%20Methods%20Available%20to%20Model%20Alzheimer's%20Disease%20Progression&rft.jtitle=Value%20in%20health&rft.au=Green,%20Colin,%20PhD&rft.date=2011-07-01&rft.volume=14&rft.issue=5&rft.spage=621&rft.epage=630&rft.pages=621-630&rft.issn=1098-3015&rft.eissn=1524-4733&rft_id=info:doi/10.1016/j.jval.2010.12.008&rft_dat=%3Cproquest_cross%3E883850576%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=883850576&rft_id=info:pmid/21839398&rft_els_id=1_s2_0_S1098301511001148&rfr_iscdi=true